GABRIEL LEUNG
CIK 1236183 · EVP & Pres. Pharma. Business · last filed 2026-06-05
GABRIEL LEUNG is an EVP & Pres. Pharma. Business who has filed 79 SEC Form 4 insider transactions across 5 companies since 2007. The most recent filing, for NVCR, was dated Jun 5, 2026. Across all open-market trades the lifetime net is −$28.3M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $2.0M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$2.05M
5
79
-$28.28M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| NVCR | Director | 101,109 | $17.78 | $1.80M | -$24.16M | 44 | 2026-06-05 |
| PERNIX THERAPEUTICS HOLDINGS, INC. (PTX) Delisted | Director | — | — | — | $0 | 3 | 2018-05-23 |
| ALBANY MOLECULAR RESEARCH INC (AMRI) Delisted | Director | 31,316 | — | — | $19.2K | 9 | 2015-03-04 |
| DCTH | Director | 21,485 | $11.72 | $251.8K | $11.8K | 7 | 2014-07-09 |
| OSI PHARMACEUTICALS INC (OSIP) Delisted | EVP & Pres. Pharma. Business | 0 | — | — | -$4.15M | 16 | 2010-06-09 |
Recent Filings
79 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-05 | NVCR | Grant (A) | +11,610 | $0 | EDGAR |
| 2026-06-03 | NVCR | Sell (S) | −2,945 | -$46.4K | EDGAR |
| 2025-06-06 | NVCR | Grant (A) | +11,215 | $0 | EDGAR |
| 2025-06-04 | NVCR | Sell (S) | −999 | -$17.3K | EDGAR |
| 2024-06-06 | NVCR | Mixed | +3,089 | -$23.0K | EDGAR |
| 2023-06-09 | NVCR | Grant (A) | +3,853 | $0 | EDGAR |
| 2022-06-10 | NVCR | Grant (A) | +2,427 | $0 | EDGAR |
| 2021-08-06 | NVCR | Mixed | — | -$121.0K | EDGAR |
| 2021-07-08 | NVCR | Mixed | — | -$152.1K | EDGAR |
| 2021-06-11 | NVCR | Grant (A) | +814 | $0 | EDGAR |